News
UnitedHealth Group stock plunged on rising medical costs, leadership shifts, and a DOJ probe, plus 2025 guidance withdrawal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback